Recently Viewed
Clear AllValue Research Rating
Quality Score 
0/0
Growth Score
0/0
Valuation Score
0/0
Momentum Score
0/0
Today’s Range
52 Week Range
Liquidity
Market cap
₹722 Cr
Revenue (TTM)
₹350 Cr
Net Profit (TTM)
₹-8 Cr
ROE
-16.5 %
ROCE
-4.9 %
P/E Ratio
--
P/B Ratio
2.2
Industry P/E
26.42
EV/EBITDA
31.7
Div. Yield
0.1 %
Debt to Equity
0.5
Book Value
₹466.2
EPS
₹-11.8
Face value
10
Shares outstanding
6,891,963
CFO
₹52.20 Cr
EBITDA
₹187.97 Cr
Net Profit
₹91.54 Cr
|
Company
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|---|---|---|---|---|---|---|---|
|
Bharat Parenterals
| -13.4 | -8.4 | -13.5 | 3.9 | 46.1 | 24.7 | -- |
|
BSE Healthcare
| -4.7 | -5.8 | -5.4 | 1.3 | 23.7 | 14.0 | 10.6 |
|
Company
|
2025
|
2024
|
2023
|
2022
|
2021
|
2020
|
2019
|
|---|---|---|---|---|---|---|---|
|
Bharat Parenterals
| -19.1 | 85.8 | 147.0 | -14.4 | 2.8 | 109.7 | -20.5 |
|
BSE Small Cap
| -6.6 | 29.0 | 47.5 | -1.8 | 62.8 | 32.1 | -6.8 |
|
BSE Healthcare
| -3.3 | 43.1 | 37.0 | -12.1 | 20.9 | 61.4 | -3.5 |
Is there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
5Y Avg -- 3Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Company |
Price (₹) | Market Cap (₹ Cr) | Revenue (TTM) | Net Profit (TTM) | OPM (%) | ROE (%) | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
|
Bharat Parenterals
|
1,047.0 | 721.6 | 349.8 | -28.6 | -4.4 | -2.5 | -- | 2.2 |
| 2,791.2 | 34,920.1 | 5,201.6 | 1,014.6 | 22.9 | 25 | 34.4 | 7.6 | |
| 7,827.5 | 19,544.3 | 2,177.5 | 200.9 | 11.3 | 26.5 | 97.3 | 23.5 | |
| 1,565.8 | 11,917.5 | 2,089.5 | 622.0 | 31.3 | 20.4 | 19.4 | 3.6 | |
| 1,332.1 | 18,429.0 | 3,078.2 | 469.4 | 26.4 | 14.9 | 42.7 | 5.1 | |
| 1,961.1 | 31,410.1 | 4,193.0 | 753.8 | 22.7 | 20.8 | 41.7 | 7.8 | |
| 4,887.1 | 22,333.8 | 2,482.3 | 853.6 | 33.7 | 18.9 | 26.2 | 5.6 | |
| 4,778.6 | 7,918.9 | 1,348.5 | 293.5 | 28.1 | 50.7 | 27 | 11.4 | |
| 3,265.0 | 7,519.5 | 1,837.4 | 326.7 | 24.7 | 44.5 | 23 | 10.0 | |
| 971.2 | 8,938.5 | 4,725.6 | 528.7 | 14.9 | 20.7 | 17.5 | 3.0 |
No Review & Analysis are available.
--
Incorporated
1992
Chairman
Bharat Desai
Managing Director
Bharat Desai
Headquarters
Vadodara, Gujarat
Website
Our rating system has guided millions of investors in the past 20 years.
The share price of Bharat Parenterals Ltd is ₹1,047.00 (BSE) as of 02-Apr-2026 IST. Bharat Parenterals Ltd has given a return of 46.06% in the last 3 years.
Since, TTM earnings of Bharat Parenterals Ltd is negative, P/E ratio is not available.
The P/B ratio of Bharat Parenterals Ltd is 2.25 times as on 02-Apr-2026, a 50 discount to its peers’ median range of 4.48 times.
PE & PB ratio at the end of financial year.
| Year | P/E Ratio | P/B Ratio |
|---|---|---|
|
2025
|
0.00
|
2.06
|
|
2024
|
44.99
|
3.31
|
|
2023
|
11.83
|
1.06
|
|
2022
|
9.36
|
1.19
|
|
2021
|
9.42
|
1.34
|
The 52-week high and low of Bharat Parenterals Ltd are Rs 1,667.20 and Rs 880.25 as of 03-Apr-2026.
Bharat Parenterals Ltd has a market capitalisation of ₹ 722 Cr as on 02-Apr-2026. As per SEBI classification, it is a Small Cap company.
Before investing in Bharat Parenterals Ltd, assess your goals, risk tolerance, and if the company aligns with your long-term plan. Carefully review its business model, financials, and valuation. Avoid making decisions based on tips or short-term trends.
₹2.00
(
New Process Alert 
Seems like you've uploaded a wrong QR code. Please upload the QR code downloaded from MF Central platform.